249 filings
8-K
DXCM
Dexcom Inc
15 Feb 24
Entry into a Material Definitive Agreement
4:15pm
8-K
DXCM
Dexcom Inc
8 Feb 24
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
4:03pm
8-K
DXCM
Dexcom Inc
8 Jan 24
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
8:02am
8-K
DXCM
Dexcom Inc
2 Nov 23
Other Events
4:19pm
8-K
DXCM
Dexcom Inc
26 Oct 23
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
4:04pm
8-K
qio he1dobf96dg1j
26 Oct 23
Other Events
4:04pm
8-K
jyr0vc
28 Aug 23
Departure of Directors or Certain Officers
8:41am
8-K
rrlnd90v3l7b p5
27 Jul 23
Dexcom Reports Second Quarter 2023 Financial Results
4:05pm
8-K
ovg7aohqjyvm
23 Jun 23
Dexcom Updates Long-Range Financial Targets
6:04pm
8-K
gfnl613f72c
19 May 23
Departure of Directors or Certain Officers
5:01pm
8-K
wxk5fi8g
5 May 23
Entry into a Material Definitive Agreement
5:16pm
8-K
0aqqfu2gqhge4j
3 May 23
Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
7:19am
8-K
w3jn0lgkbcc2kl htqd
2 May 23
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
7:16am
8-K
34a8wg4may7aq5qgn 9n
27 Apr 23
Dexcom Reports First Quarter 2023 Financial Results
12:00am
8-K
oduqkj8y9 bvnj
9 Feb 23
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
4:05pm
8-K
n58zw dzjs
9 Jan 23
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
8:03am
8-K
v251rico
27 Oct 22
Dexcom Reports Third Quarter 2022 Financial Results
4:05pm
8-K
eg5ocd6q
31 Aug 22
Departure of Directors or Certain Officers
5:01pm
8-K
6kzjm
5 Aug 22
Other Events
4:52pm
8-K
pi1qcxx1
28 Jul 22
Other Events
4:23pm